Microbiota-dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82 rubidium PET/CT

Andreas Knudsen; Thomas Emil Christensen; Kristina Thorsteinsson; Adam Ali Ghotbi; Philip Hasbak; Anne Mette Lebech; Susanne Dam Nielsen; Johannes Roksund Hov; Rolf Berge; Rasmus Sejersten Ripa; Andreas Kjær; Marius Trøseid

doi:10.1097/QAI.0000000000001044

Microbiota-dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82 rubidium PET/CT

Andreas Knudsen, Thomas Emil Christensen, Kristina Thorsteinsson, Adam Ali Ghotbi, Philip Hasbak, Anne Mette Lebech, Susanne Dam Nielsen, Johannes Roksund Hov, Rolf Berge, Rasmus Sejersten Ripa, Andreas Kjær, Marius Trøseid

Research output: Contribution to journal › Letter › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	e83-e85
Journal	Journal of Acquired Immune Deficiency Syndromes
Volume	72
Issue number	4
DOIs	https://doi.org/10.1097/QAI.0000000000001044
State	Published - 1 Aug 2016
Externally published	Yes

Access to Document

10.1097/QAI.0000000000001044

Cite this

Knudsen, A., Christensen, T. E., Thorsteinsson, K., Ghotbi, A. A., Hasbak, P., Lebech, A. M., Nielsen, S. D., Hov, J. R., Berge, R., Ripa, R. S., Kjær, A., & Trøseid, M. (2016). Microbiota-dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82 rubidium PET/CT. Journal of Acquired Immune Deficiency Syndromes, 72(4), e83-e85. https://doi.org/10.1097/QAI.0000000000001044

@article{f2e685f256e041f9a3f2a9c1a0620ff2,

title = "Microbiota-dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82 rubidium PET/CT",

author = "Andreas Knudsen and Christensen, {Thomas Emil} and Kristina Thorsteinsson and Ghotbi, {Adam Ali} and Philip Hasbak and Lebech, {Anne Mette} and Nielsen, {Susanne Dam} and Hov, {Johannes Roksund} and Rolf Berge and Ripa, {Rasmus Sejersten} and Andreas Kj{\ae}r and Marius Tr{\o}seid",

year = "2016",

month = aug,

day = "1",

doi = "10.1097/QAI.0000000000001044",

language = "English",

volume = "72",

pages = "e83--e85",

journal = "Journal of Acquired Immune Deficiency Syndromes",

issn = "1525-4135",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "4",

}

Knudsen, A, Christensen, TE, Thorsteinsson, K, Ghotbi, AA, Hasbak, P, Lebech, AM, Nielsen, SD, Hov, JR, Berge, R, Ripa, RS, Kjær, A & Trøseid, M 2016, 'Microbiota-dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82 rubidium PET/CT', Journal of Acquired Immune Deficiency Syndromes, vol. 72, no. 4, pp. e83-e85. https://doi.org/10.1097/QAI.0000000000001044

Microbiota-dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82 rubidium PET/CT. / Knudsen, Andreas; Christensen, Thomas Emil; Thorsteinsson, Kristina et al.
In: Journal of Acquired Immune Deficiency Syndromes, Vol. 72, No. 4, 01.08.2016, p. e83-e85.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Microbiota-dependent marker TMAO is not associated with decreased myocardial perfusion in well-treated HIV-infected patients as assessed by 82 rubidium PET/CT

AU - Knudsen, Andreas

AU - Christensen, Thomas Emil

AU - Thorsteinsson, Kristina

AU - Ghotbi, Adam Ali

AU - Hasbak, Philip

AU - Lebech, Anne Mette

AU - Nielsen, Susanne Dam

AU - Hov, Johannes Roksund

AU - Berge, Rolf

AU - Ripa, Rasmus Sejersten

AU - Kjær, Andreas

AU - Trøseid, Marius

PY - 2016/8/1

Y1 - 2016/8/1

UR - http://www.scopus.com/inward/record.url?scp=84965056939&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000001044

DO - 10.1097/QAI.0000000000001044

M3 - Letter

C2 - 27152465

AN - SCOPUS:84965056939

SN - 1525-4135

VL - 72

SP - e83-e85

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

IS - 4

ER -